These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6110871)

  • 1. Rheumatic manifestations in leprosy.
    Lancet; 1981 Mar; 1(8221):648-9. PubMed ID: 6110871
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of rheumatic manifestations and serologic abnormalities in patients with lepromatous leprosy.
    Chavez-Legaspi M; Gomez-Vazquez A; García-De La Torre I
    J Rheumatol; 1985 Aug; 12(4):738-41. PubMed ID: 3877167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatic manifestations in leprosy].
    Pereira HL; Ribeiro SL; Sato EI
    Acta Reumatol Port; 2008; 33(4):407-14. PubMed ID: 19078860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylene glycol precipitates in serum during and after erythema nodosum leprosum--study of their composition and anticomplementary activity.
    Saha K; Chakrabarty AK; Sharma VK; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):44-8. PubMed ID: 6538557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically-active mediators of hypersensitivity reactions in the blood of lepromatous patients with erythema nodosum leprosum.
    Saha K; Lahiri SC
    Lepr Rev; 1981 Dec; 52(4):315-20. PubMed ID: 7031390
    [No Abstract]   [Full Text] [Related]  

  • 6. [The polyarthritis of leprosy. Apropos of a case of diffuse, symmetrical and febrile polyarthritis revealing a lepromatous leprosy previously unrecognized].
    Manigand G; Paillas J; Lardy B; Deparis M
    Sem Hop; 1969 Feb; 45(8):543-52. PubMed ID: 4182540
    [No Abstract]   [Full Text] [Related]  

  • 7. The rheumatic manifestations of leprosy (Hansen disease).
    Albert DA; Weisman MH; Kaplan R
    Medicine (Baltimore); 1980 Nov; 59(6):442-8. PubMed ID: 6969346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of acute lepromatous uveitis: a case report.
    Murray PI; Muir MG; Rahi AH
    Lepr Rev; 1986 Jun; 57(2):163-8. PubMed ID: 2943955
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic manifestations of leprosy: clinical aspects.
    Pernambuco JC; Cossermelli-Messina W
    J Rheumatol; 1993 May; 20(5):897-9. PubMed ID: 8336321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a reactivation of cellular immunity in erythema nodosum leprosum?].
    Stach JL; Fumoux F; Digoutte JP
    Acta Leprol; 1981; 85():83-92. PubMed ID: 6805239
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
    Valentijn RM; Faber WR; Lai A Fat RF; Chan Pin Jie JC; Daha MR; van Es LA
    Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Relationship of C1q-precipitins with leprosy.
    Faber WR; Asghar SS; Cormane RH
    Int J Lepr Other Mycobact Dis; 1974; 42(3):334. PubMed ID: 4477564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Joint manifestations in 2 cases of leprosy].
    David-Chaussé J; Texier L; Dehais J; Bullier R; Louis-Joseph L
    Rev Rhum Mal Osteoartic; 1978 May; 45(5):361-5. PubMed ID: 675125
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid-factor-like substance and antistreptolysin O antibody in leprosy serum. Significance in erythema nodosum leprosum.
    Abe M; Chinone S; Hirako T
    Int J Lepr Other Mycobact Dis; 1967; 35(3):336-44. PubMed ID: 4195462
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of clinical leprosy.
    Turk J
    Proc R Soc Med; 1970 Oct; 63(10):1053-6. PubMed ID: 5483516
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatic and other musculoskeletal manifestations and autoantibodies in childhood and adolescent leprosy: significance and relevance.
    Chopra A
    J Pediatr (Rio J); 2014; 90(5):431-6. PubMed ID: 24973468
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatological manifestations of leprosy.
    Mandal SK; Sarkar RN; Sarkar P; Datta S; Bandyopadhyay R; Bandyopadhyay D; Pain S
    J Indian Med Assoc; 2008 Mar; 106(3):165-6. PubMed ID: 18712135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for circulating immune complexes in lepromatous leprosy.
    Moran CJ; Ryder G; Turk JL; Waters MF
    Lancet; 1972 Sep; 2(7777):572-3. PubMed ID: 4115742
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.